It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Receptor dimerization of urokinase-type plasminogen activator receptor (uPAR) was previously identified at protein level and on cell surface. Recently, a dimeric form of mouse uPAR isoform 2 was proposed to induce kidney disease. Here, we report the crystal structure of human uPAR dimer at 2.96 Å. The structure reveals enormous conformational changes of the dimer compared to the monomeric structure: D1 of uPAR opens up into a large expanded ring that captures a β-hairpin loop of a neighboring uPAR to form an expanded β-sheet, leading to an elongated, highly intertwined dimeric uPAR. Based on the structure, we identify E49P as a mutation promoting dimer formation. The mutation increases receptor binding to the amino terminal fragment of its primary ligand uPA, induces the receptor to distribute to the basal membrane, promotes cell proliferation, and alters cell morphology via β1 integrin signaling. These results reveal the structural basis for uPAR dimerization, its effect on cellular functions, and provide a basis to further study this multifunctional receptor.
The structural basis for urokinase-type plasminogen activator receptor (uPAR) dimerization is not understood. Here, the authors solve the crystal structure of soluble uPAR dimers, identifying substantial structural changes compared to the monomer.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Li, Yongdong 2 ; Hanlin, Li 2 ; Cao Yingping 4 ; Chen, Liqing 5 ; Jiang Longguang 2 ; Cai, Yuan 6
; Huang Mingdong 1
1 Fuzhou University, Fuzhou, College of Chemistry, Fujian, China (GRID:grid.411604.6) (ISNI:0000 0001 0130 6528); Fuzhou University, College of Biological Science and Engineering, Fuzhou, China (GRID:grid.411604.6) (ISNI:0000 0001 0130 6528)
2 Fuzhou University, Fuzhou, College of Chemistry, Fujian, China (GRID:grid.411604.6) (ISNI:0000 0001 0130 6528)
3 Tsinghua University, Beijing, China (GRID:grid.12527.33) (ISNI:0000 0001 0662 3178)
4 Fujian Medical University Union Hospital, Department of Clinical Laboratory, Fuzhou, China (GRID:grid.411176.4) (ISNI:0000 0004 1758 0478)
5 Arizona State University, School of Molecular Sciences, Tempe, USA (GRID:grid.215654.1) (ISNI:0000 0001 2151 2636)
6 Fuzhou University, College of Biological Science and Engineering, Fuzhou, China (GRID:grid.411604.6) (ISNI:0000 0001 0130 6528); Fuzhou University, Key Laboratory of Marine Enzyme Engineering, Fuzhou, China (GRID:grid.411604.6) (ISNI:0000 0001 0130 6528)




